Medically reviewed by Dr. Jyoti Rao, Consultant, Medical Affairs | Last reviewed August 2026
Key Takeaways
- Red flags are recognition triggers, not a diagnosis. Their purpose is to lower the threshold for initiating a structured ATTR-CM workup.
- An important cardiac trigger is heart failure with preserved ejection fraction plus increased left ventricular wall thickness, especially when accompanied by low or discordant electrocardiogram (ECG) voltage.
- Extracardiac clues, such as bilateral carpal tunnel syndrome, lumbar spinal stenosis, and spontaneous biceps tendon rupture, often precede the cardiac presentation by years.
- A single red flag may be nonspecific; a cluster of cardiac and extracardiac features together substantially raises pretest suspicion.
Red Flags Are Recognition Triggers, Not a Diagnosis
A red flag in ATTR-CM is a clinical feature common enough in the disease and unusual enough in routine cardiology that it should prompt a clinician to ask whether transthyretin amyloid is present. No single red flag confirms or excludes the diagnosis. Their value lies in the pre-diagnostic stage as it changes the pretest probability and prompts the decision to investigate. Once suspicion is raised, the next step is a structured diagnostic evaluation that includes monoclonal-protein assessment and appropriate cardiac imaging to distinguish ATTR-CM from other forms of cardiac amyloidosis.
Cardiac Features That Should Raise Suspicion
The cardiac red flags cluster around an infiltrated, stiff ventricle that behaves differently from typical hypertensive or ischemic heart disease. Features worth treating as triggers include:
- Heart failure with preserved ejection fraction accompanied by increased left ventricular wall thickness
- Low QRS voltage on the ECG or a mismatch between low voltage and a thick-walled ventricle on imaging
- A pseudoinfarct pattern on the ECG without a corresponding coronary territory
- Conduction system disease, including atrioventricular (AV) block, and unexplained atrial arrhythmia
- Intolerance to previously tolerated antihypertensives or standard heart failure medications, or blood pressure that falls as the heart disease progresses
- Aortic stenosis that’s discordant or low-flow, low-gradient, particularly in older patients
Extracardiac Clues Often Appear Before the Heart Is Recognized
Because transthyretin amyloid is a systemic process, several non-cardiac syndromes can precede the cardiac diagnosis, sometimes by years. Recognizing them in a patient who subsequently develops unexplained heart failure can raise suspicion and potentially shorten the path to diagnosis. The most useful extracardiac clues include:
- Bilateral carpal tunnel syndrome, particularly when it required surgical release
- Lumbar spinal stenosis
- Spontaneous rupture of the distal biceps tendon
- Peripheral sensorimotor or autonomic neuropathy, including unexplained orthostatic symptoms or gastrointestinal dysmotility
None of these is specific to amyloidosis on its own. Their diagnostic significance increases when they appear together or when they accompany the cardiac features above in the same patient.
Red Flags Should Lower the Threshold to Begin the Workup
The practical purpose of the red flag list is to convert a vague clinical impression into a decision to test. When a compatible cardiac picture coincides with one or more extracardiac clues, the reasonable next step is to enter the structured diagnostic pathway rather than to attribute symptoms to age, hypertension, or coronary disease by default. When these features are present together, a structured amyloidosis workup should be initiated rather than attributing symptoms to more common conditions by default.
Practical Recognition Checklist
In an older patient with unexplained heart failure, ask:
- Is there preserved ejection fraction with increased wall thickness?
- Is the ECG voltage low or discordant with the imaging wall thickness?
- Is there conduction disease or unexplained atrial arrhythmia?
- Has the patient stopped tolerating antihypertensives or standard heart failure drugs?
- Is there a history of bilateral carpal tunnel syndrome, lumbar spinal stenosis, or biceps tendon rupture?
- Are there features of peripheral or autonomic neuropathy?
Clinical Decision Point
The practical purpose of a red flag is to prompt the clinician to decide whether further evaluation for ATTR-CM is warranted. A single nonspecific finding may not justify a full amyloid workup, but a cardiac phenotype that doesn't fit hypertensive or ischemic disease—especially alongside an extracardiac clue such as prior bilateral carpal tunnel release—should move ATTR-CM from an afterthought to an active question. The recognition step ends here; the structured diagnostic sequence carries it forward.
Frequently Asked Questions
What are the main red flags for ATTR-CM?
The core cardiac red flags are heart failure with preserved ejection fraction plus increased left ventricular wall thickness, low or discordant ECG voltage, conduction disease, intolerance to standard heart failure or blood pressure drugs, and low-flow or discordant aortic stenosis. Key extracardiac clues include bilateral carpal tunnel syndrome, lumbar spinal stenosis, spontaneous biceps tendon rupture, and peripheral or autonomic neuropathy.
Why does carpal tunnel syndrome matter in ATTR-CM?
Transthyretin amyloid is systemic, and tendon and ligament deposition can cause bilateral carpal tunnel syndrome years before the heart is affected. A history of bilateral carpal tunnel release, particularly when paired with later unexplained heart failure, is a recognized clue that should raise suspicion.
Does a single red flag confirm ATTR-CM?
No. Each red flag is nonspecific on its own. They are recognition triggers that raise pretest probability and prompt a structured workup; ATTR-CM diagnosis is based on the integrated clinical, laboratory, and imaging findings, including monoclonal-protein assessment and bone scintigraphy, with tissue confirmation when needed.
What should I do after identifying red flags?
Move into the diagnostic pathway. Identifying red flags is the trigger to begin screening and differential diagnosis, not the end of the assessment.
Part of the Spotlight On ATTR-CM resource center.
References:
- World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM). Global Heart
- Transthyretin Amyloid Cardiomyopathy—2025 Update: Current Diagnostic Approaches and Emerging Therapeutic Options. Journal of Clinical Medicine
- Cardiac Amyloidosis Red Flags: What All the Cardiologist Have to Know. International Journal of Cardiology: Cardiovascular Risk and Prevention
This content is intended for healthcare professionals for educational purposes and isn't a substitute for individual clinical judgment. It was developed with AI assistance and reviewed by a qualified healthcare professional for clinical accuracy prior to publication.